healthcare
Asian Healthcare Fund invests in Wellspring clinic chain
Delhi-based Asian Healthcare Fund (AHF) has invested in Wellspring Healthcare, which runs eight primary care clinics in Mumbai under the Healthspring Community Medical Centres brand. Financial details of the deal were not disclosed.
China’s GSR leads restructuring round for Mirabilis Medica
China-focused GSR Ventures is leading a $7 million restructuring round for Mirabilis Medica with a view to helping the company expand its footprint outside the US.
China.com to sell LP stake in New Horizon fund to AlpInvest
China.com, a news agency listed on Hong Kong Growth Enterprise Market (GEM) board, will sell its entire stake in New Horizon Capital IV to AlpInvest Partners for $516,000.
DEG invests $12m in Indian hospital chain
German Investment and Development (DEG), a development finance institution, has invested INR700 million ($12 million) in the Ivy Healthcare Group which runs a chain of super specialty hospitals in the north Indian state of Punjab.
Quadrant-backed Virtus Health jumps 9% on ASX debut
Shares in Virtus Health, an Australian in-vitro fertilization company backed by Quadrant Private Equity, closed up 9% at A$6.20 on its first day of trading on the Australian Securities Exchange. The IPO had been priced at the top end of the indicative...
IFC to support BioVeda’s $200m China fund
International Financial Corp.(IFC), the World Bank investment arm, plans to commit up to $20 million to the latest fund launched by healthcare-focused firm BioVeda China Fund (BVCF).
Apax makes $22.6m from Apollo Hospitals partial exit
Apax Partners has made another partial exit from India’s Apollo Hospitals, generating proceeds of of INR1.28 billion ($22.6 million) via the National Stock Exchange.
CITIC PE completes $370m 3SBio take-private
Chinese biotechnology firm 3SBio will delist from NASDAQ after shareholders voted in favor of a privatization bid from a group led by the company’s CEO and CITIC Private Equity. The deal, which values 3SBio at $370 million, is the eighth successful...
Temasek-backed healthcare firm HCG acquires majority stake in BACC
HealthCare Global Enterprises (HCG), an Indian cancer treatment specialist backed by Temasek Holdings, has acquired a majority stake in Bangalore Assisted Conception Centre (BACC), a leading provider of fertility care. Details of the transaction were...
Korea’s Access Bio goes public, STIC PE expects 5x return
STIC Private Equity has made a partial exit from Korean biotech firm Access Bio after the company went public on the KOSDAQ exchange. The PE firm sold shares in two tranches – one just before the IPO and one during it – and has generated a money multiple...
Invictus Oncology gets $2m from Navam, Aarin
Indian investors Navam Capital and Aarin Capital have invested INR10.5 million ($1.88 million) in Delhi-based Invictus Oncology as part of a Series A round of funding.
India Value Fund-backed Manipal invests in Ankur Healthcare
India Value Fund-backed Manipal Health Enterprises has committed INR400 million ($7.27 million) to Ankur Healthcare, which specializes in infertility treatment.
Australia's Quadrant exits Virtus Health, Summerset
Quadrant Private Equity has exited its investment in fertility services provider Virtus Health via a A$339 million ($330 million) IPO, while making another partial exit from retirement village chain Summerset.
Phillip PE sees 7x return on biotech start-up
Inviragen had inauspicious beginnings. The firm came about through a marriage of convenience between two biotech start-ups that couldn't get funding: US-based Inviragen was working on dengue fever vaccine but had no capital for clinical trials; over in...
UK drug developer Vectura partners PE on China JV
Vectura, a UK-based drug company, has teamed up with Hong Kong-based PE investor Zendex Bio Strategy and Tianjin KingYork Group to form a joint venture that will develop respiratory products in China and other Asian markets.
Goldman invests $20m in Indian medical device manufacturer
Goldman Sachs’ private equity unit has committed INR1.1 billion ($20 million) to BPL Medical Technologies, a subsidiary of listed Indian consumer products manufacturer BPL. This is Goldman's third investment in the Indian healthcare sector.
Hony-invested Biosensors completes bolt-on
Biosensors International, a Singapore-listed medical device company backed by Hony Capital, has acquired Spectrum Dynamics, an Israel-based medical imaging and clinical applications company, for $51.13 million.
IFC, Sabre to invest $40m in Everstone-backed Indian hospital chain
Ravindranath GE Medical Associates (RGE), which operates a chain of eight hospitals across India under the Global Hospitals brand, will receive $15 million from Sabre Partners and $25 million from the International Finance Corporation.
Japan's Takeda buys Singapore biopharma start-up
PE-backed Singapore biopharmaceutical start-up Inviragen is to be acquired by Japan's Takeda Pharmaceutical for $250 million.
Temasek-invested US drug developer targets IPO
Portola Pharmaceuticals, a US-based drug developer whose largest shareholder is Temasek Holdings, plans to raise $127 million through a NASDAQ IPO. The other backers include MPM Capital, Prospect Venture Partners, Brookside Capital, Sutter Hill Ventures,...
Quadrant-backed Summerset eyes Australia listing
Summerset, a New Zealand care home operator backed by Quadrant Private Equity, is seeking to list on the Australian Securities Exchange in response to increased interest from local investors.
Mercury takes 30% stake in Australia's Novotech
Mercury Capital has taken a 30% stake in Novotech, Australia's largest independent clinical trials provider, with a view to aiding its Asia-Pacific expansion. The amount invested was not disclosed.
Quadrant-backed Virtus Health launches IPO
Quadrant Private Equity-owned in-vitro fertilization (IVF) business Virtus Health launched its IPO road show on Monday. It is poised to be the largest equity offering since SCA Property in November last year and the biggest significant private equity-backed...
Fosun Pharma, Pramerica-Fosun buy Israel’s Alma Lasers
Shanghai Fosun Pharmaaceutical, a subsidiary of China’s Fosun International, and the Pramerica-Fosun China Opportunity Fund, will be around $240 million to acquire up to 95.6% of Israel-based Alma Lasers.